Projects funded by the ACRF
We provide capital grants for the establishment of capital works and facilities (including scientific equipment and other technologies), and national enterprises in support of all aspects of cancer research, including but not limited to cell and molecular biology, epidemiology, prevention and drug development.
The ACRF is a ‘seed’ funding body and is therefore interested in applications for larger scale research projects with value over and above the amount sought directly from ACRF. We expect applicants to leverage ACRF grants to secure any ‘gap’ funding and also to feature multi-disciplinary teams, collaborations and evidence of the translational impacts at a clinical level (with patients).
Assessment of applications
All applications are considered and assessed by the ACRF’s Medical Research Advisory Committee (MRAC), a group of highly distinguished research scientists who are appointed by the ACRF’s Board of Trustees. The procedures of the MRAC are similar to those employed by the National Health & Medical Research Council and include the assessment of applications by referees and independent expert assessors, as well as site visits and interviews of selected short-listed applicants.
The MRAC’s recommendations for funding are reviewed and finalised by the Foundation’s Board of Trustees.
2017 Grant Applications
Our 2017 Grant Round has now closed. Thank you to everyone who applied for an ACRF Grant. We received 13 applications, of exceptional standard, totalling over $44million.
The Medical Research Advisory Committee has short-listed seven applicants who will be interviewed in September.
The official announcement of our 2017 ACRF Grants will be made in November.
2018 Major Grant Round
In keeping with the mission of the Foundation, to promote bold and significant programs that will facilitate major advances in the prevention, early detection, treatment and/or management of cancer, ACRF invites applications for a special $10 million Grant.
A detailed written application will be accepted from Monday 5 March 2018 and
will close on Friday 4 May 2018.
A special expert panel, nominated by the MRAC, will review the applications for scientific merit and select a short list to proceed to interview including a site visit.